comparemela.com

Latest Breaking News On - Glympse bio - Page 1 : comparemela.com

Deep tech sustains healthtech dealmaking momentum in SE Asia

Southeast Asia's healthtech sector has defied the wider dealmaking slowdown to maintain its momentum in the first nine months of 2023.

Glympse bioVeronica utamiAnkit agrawalGenome science initiative bgsiNorthstar groupYinglan tanSoutheast asiaSunbird bioQuadria capitalGenome science initiativeSoutheast asian

Woodcock set to retire from FDA in early 2024—Chutes & Ladders

Woodcock set to retire from FDA in early 2024—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United statesJeremy caldwellGabrielle massonGraham owensCarole huntsmanEric perakslisNoema pharmaMano iyerMax bayerLisa shamonRamon felcianoRobert califfMichael kauffmanThomas heathmanAeglea biotherapeuticsWilliam shakespeare

Mural Oncology spins out from Alkermes with $275M, lead immunotherapy program

The spinoff between Mural and Alkermes created two pure-play companies.

United statesMarc goodmanGlympse bioAmerican society of clinical oncology annual meetingBristol myers squibbMural oncologyCaroline loewBristol myersAmerican societyClinical oncology annual

Alkermes separates cancer drug business as new company Mural

BioPharma

Glympse bioCaroline loewMerck coBristol myers squibbDive briefMural oncologyNasdaq global market

Mural Oncology Launches To Advance Pipeline Of Novel Engineered Cytokine Immunotherapies

Mural Oncology Launches To Advance Pipeline Of Novel Engineered Cytokine Immunotherapies
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Caroline loewDave borahVicki goodmanGlympse bioScott jacksonSmithkline beechamBenjamin hickeyDsusan altschullerMadam cutlerMaiken keson brookesEli lillyForum pharmaceuticalsYm biosciencesCelator pharmaceuticalsImclone systemsInvestor relations corporate affairs

vimarsana © 2020. All Rights Reserved.